Postoperative Pain Management Market Size And Growth Factors Research And Projection 2026: Bayer AG, DURECT Corporation, Pfizer, BTG International Ltd

Postoperative pain includes all type of acute pain that occurs due to injuries and can resolve in appropriate healing period. Such pain often responds to analgesic medication and treatment of the precipitating cause. Postoperative pain can also cause cardiovascular, respiratory, endocrine, metabolic etc. The aim of any postoperative pain treatment is to mobilize the patient as early as possible. It allows the patient to drink and eat as early as possible and to be able to deep breathe and cough. If patients are not given proper postoperative pain treatment, they can have risk of cardiac problems, chest infections, depression, wound increased infection rate and hypoxia. Postoperative pain treatment evolved with different understanding of how drugs affect in our body when used in combinations.
Opioids and Non-steroidal anti-inflammatory drugs are expected to contribute major share in terms of value to the overall postoperative pain market. Opioids act as a substance that acts on the opioid receptor to produce morphine like effects. They are most often used to relieve main. Non-steroidal anti-inflammatory drugs are used to treat pain, inflammation and fever.

Request Sample Copy Of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/154

Global Postoperative Pain Management Market Taxonomy
On the basis of product type, the global market is classified as follows:
• Opioids
◦ Fentanyl
◦ Morphine
◦ Meperidine
◦ Others
• Non-steroidal anti-inflammatory drugs
◦ Paracetamol (acetaminophen)
◦ Ibuprofen
◦ Ketorolac tromethamine
• Cyclooxygenase-2-selective inhibitors
◦ Celecoxib
◦ Etoricoxib
◦ Rofecoxib
• Glucocorticods
• Local anesthetics
• Antidepressants
• Others
On the basis of type of pain, the global market is classified as follows:
• Neuropathic Pain
• Nociceptive Pain
◦ Visceral Pain
◦ Somatic Painpos
◦ Others

Prevalent Scenarios in Postoperative Pain Management Market
Increasing number of surgical procedure is expected to act as a value-driver to the global postoperative pain management market. As per the World Bank, in the U.S. there were 30,537 number of surgical procedures performed in 2012. As per National Center for Health Statistics, of overall surgical procedures half of the procedure requires postoperative pain medication which provides high opportunity for manufacturers. As per Centers for Disease Control and Prevention (CDC), every year there are around 41 million visits in emergency department due to trauma. Around 450,000 burns require medical attention annually. Increase in trauma cases to act as a fuel to the overall growth of postoperative pain management market.

Some postoperative pain drugs include side effects. Despite the many advancement in postoperative pain management, opioids are still considered as the mainstay pain therapy in many settings. All opioids have significant side effects that are limiting its use. One of the major side-effects associated with the use of opioid is respiratory depression.

Highly Fragmented Market
The global postoperative pain management market is highly fragmented, owing to the participation of many established and emerging players. Major players involved in the market are Bayer AG, DURECT Corporation, Pfizer Inc., BTG International Ltd, Novartis AG, A.P. Pharma, Inc., among others.

You may also be interested in these Insights Access PDF @ https://www.coherentmarketinsights.com/insight/request-pdf/154

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.